Bioharvest Sciences Ratios (2023-2025) | BHST

Ratios Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
Gross Margin (Quarter) 40.22%44.52%50.73%56.19%51.47%56.80%56.65%58.46%59.73%61.43%57.63%
EBT Margin (Quarter) 103.64%53.32%160.07%-123.15%-11.40%-41.12%-40.51%-29.26%-47.46%-27.02%-25.02%
EBIT Margin (Quarter) 104.55%61.96%-384.58%-26.65%-29.47%-32.15%-23.18%-21.87%-21.32%-10.15%-12.36%
EBITDA Margin (Quarter) 104.55%61.96%-384.58%-26.65%-29.47%-32.15%-23.18%-21.87%-21.32%-10.15%-12.36%
Operating Margin (Quarter) 104.55%61.96%-384.58%-26.65%-29.47%-32.15%-23.18%-21.87%-21.32%-10.15%-12.36%
Net Margin (Quarter) 103.64%53.32%160.07%-123.15%-11.40%-41.12%-40.51%-29.75%-47.92%-27.72%-22.63%
FCF Margin (Quarter) -17.13%-59.80%-25.37%12.44%-19.07%-105.33%-9.45%-10.15%-18.37%-69.58%
Efficiency
Inventory Average (Quarter) 3.06M3.11M2.88M3.42M3.83M4.07M4.28M4.50M
Assets Average (Quarter) 26.42M25.41M25.80M27.19M31.49M41.43M
Equity Average (Quarter) -41.09M2.73M0.23M
Invested Capital (Quarter) -82.98M1.33M4.14M5.24M-0.88M25.60M
Asset Utilization Ratio (Quarter) 0.850.991.071.111.040.83
Leverage & Solvency
Interest Coverage Ratio (Quarter) 18.0812.95-8.02-0.28-4.70-3.58-1.34-2.96-0.82-0.60-0.93
Debt to Equity (Quarter) -0.012.940.01
Debt Ratio (Quarter) 0.040.160.00
Equity Ratio (Quarter) -5.570.050.160.05-0.030.53
Times Interest Earned (Quarter) 18.0812.95-8.02-0.28-4.70-3.58-1.34-2.96-0.82-0.60-0.93
Valuation
Enterprise Value (Quarter) -1.74M-1.74M-5.36M-2.39M-5.36M-5.36M-2.39M-3.40M-3.73M-2.39M-23.02M
Return Ratios
Return on Sales (Quarter) 0.01%0.01%0.02%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Capital Employed (Quarter) -137.57%-62.66%-106.13%-72.58%-33.55%-16.52%
Return on Assets (Quarter) 0.00%-0.01%0.00%0.00%0.00%0.00%
Return on Equity (Quarter) 0.00%-0.05%-0.38%